Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Cardiovascular Systems, Inc. CSII
$20.00
На 18:00, 12 мая 2023
-12.50%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
843960000.00000000
-
week52high
20.00
-
week52low
12.26
-
Revenue
236222000
-
P/E TTM
-21
-
Beta
0.73702400
-
EPS
-0.96000000
-
Last Dividend
0.00000000
-
Next Earnings Date
31 июл 2023 г. в 20:00
Описание компании
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. In addition, it offers guidewires, catheters, balloons, embolic protection system, and other OAS support products. Cardiovascular Systems, Inc. has a partnership with Chansu Vascular Technologies, LLC to develop novel peripheral and coronary everolimus drug-coated balloons. The company was formerly known as Shturman Cardiology Systems, Inc. and changed its name to Cardiovascular Systems, Inc. in January 2003. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| SVB Leerink | Outperform | Outperform | 05 мая 2022 г. |
| SVB Leerink | Outperform | Outperform | 04 февр 2022 г. |
| Needham | Hold | Buy | 17 ноя 2021 г. |
| SVB Leerink | Outperform | Outperform | 10 ноя 2021 г. |
| Guggenheim | Neutral | Buy | 10 ноя 2021 г. |
| Barclays | Equal-Weight | 21 дек 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Sedo Sandra | D | 110291 | 267 | 12 ноя 2022 г. |
| Rempe Stephen J. | D | 79401 | 6175 | 18 авг 2022 г. |
| Points Jeffrey S. | D | 168915 | 12752 | 18 авг 2022 г. |
| Ward Scott R. | D | 807438 | 77028 | 18 авг 2022 г. |
| Sedo Sandra | D | 110558 | 9873 | 18 авг 2022 г. |
| Rosenstein Alexander | D | 144580 | 10955 | 18 авг 2022 г. |
| Aronson Martha Goldberg | D | 0 | 2411 | 15 авг 2022 г. |
| Aronson Martha Goldberg | A | 12411 | 2411 | 15 авг 2022 г. |
| Rempe Stephen J. | D | 85576 | 2005 | 12 авг 2022 г. |
| Hastings John M. | D | 53652 | 1628 | 12 авг 2022 г. |
Новостная лента
Cardiovascular Systems (CSII) Finishes ECLIPSE Trial Enrollment
Zacks Investment Research
05 апр 2023 г. в 10:40
Cardiovascular Systems' (CSII) ECLIPSE clinical trial data is likely to help physicians form an optimal treatment plan for patients with severely calcified coronary arteries.
Cardiovascular Systems (CSII) Ails From Soft Volume, Macro Woes
Zacks Investment Research
20 мар 2023 г. в 11:28
Tough competition and consistent net loss continue to pose threats to Cardiovascular Systems (CSII).
Abbott Acquires Cardiovascular Systems: Key Takeaways For Investors
Seeking Alpha
15 февр 2023 г. в 16:57
Abbott Laboratories expands its cardiovascular pipeline with the relatively small acquisition of Cardiovascular Systems, Inc. Cardiovascular Systems investors get a way out of a cash-burning stock at a decent price. The timing of the deal is opportunistic for Abbott.
Abbott Buying Cardiovascular Systems: Details (ABT)
Pulse2
10 февр 2023 г. в 15:15
Abbott (NYSE: ABT) is buying Cardiovascular Systems (CSI). These are the details.
Cardiovascular Systems (CSII) Q2 Earnings, Revenues Miss
Zacks Investment Research
10 февр 2023 г. в 10:32
With the announcement of the merger agreement with Abbott, Cardiovascular Systems (CSII) refrains from providing any update on the 2023 guidance.